stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

BFF Bank S.p.A.

Italy · Milan: BFF.MI · Market cap: $286M · P/E: 15.1 · P/S: 0.7

BFF Bank is an Italian specialty lender that pays suppliers of public administrations and healthcare providers upfront, then collects the money owed to them by the government later.

BFF Bank is a specialist finance company that makes money from a simple but slow-moving problem: governments and public hospitals are reliable payers, but they pay late. When a company supplies goods or services to an Italian public administration or a healthcare provider, it may wait months for its invoice to be paid. BFF steps in and buys that unpaid invoice at a discount, handing the supplier cash right away. Then BFF waits for the government to pay and keeps the difference. This is called non-recourse factoring — the supplier gets its money and walks away, and BFF carries the risk of collecting from the public body.

BFF Bank S.p.A. (BFF.MI) Non-recourse factoring of trade receivables due from Public Administrations: line art illustration of faceless clerk at a desk sorting stacks of invoices from Italian public bodies
Public invoice factoring
BFF Bank buys unpaid invoices owed by public bodies and collects the money itself.

The business runs on two segments. The larger one is factoring and lending to suppliers of public administrations and healthcare providers, mostly in Italy but also in Croatia, Poland, Portugal, and a few other European countries. The smaller segment covers securities services — things like custody, settlement, and payment services for banks and investment firms. BFF built its edge over decades by knowing exactly how slowly each public body pays and pricing that delay correctly, so a pile of slow government invoices becomes a steady, predictable stream of income rather than a gamble. BFF has a history worth knowing. It started inside an Italian banking group in the 1980s, focused squarely on pharma suppliers waiting on Italy's national health service, and later became Banca Farmafactoring before going public in 2017 under the BFF name. It grew by expanding into new countries and by buying portfolios of public-sector receivables. The company pays a substantial dividend, which is one reason income-focused investors follow it.


The risks are real and easy to understand. BFF's fortunes are tied to how fast governments pay and to the health of public budgets. Its loan book is concentrated in public-sector exposure, so a slowdown in payments or a change in the rules around selling invoices to the state directly hits the whole business. Italian regulators have also scrutinized how the bank classifies some of its exposures. In short, BFF is a well-oiled machine for turning bureaucratic delay into cash — as long as the bureaucracy keeps paying, and pays roughly on the schedule BFF expects.

Saved answer · last researched 12 Nov 2026